Perinatal hypoxic-ischemic encephalopathy (HIE) is associated with high neonatal mortality and severe long-term neurologic morbidity. The molecular mechanisms and the pathway of brain injury in infants with HIE remain largely elusive. Although therapeutic hypothermia is the current standard of care for newborns with moderate to severe HIE, nearly half of affected infants treated with hypothermia still die or suffer significant neurologic disability. Thus, there is an urgent need to further investigate the underlying mechanisms and to develop additional treatment strategies. Recently, we discovered in an animal model of neonatal rats that hypoxic-ischemic (HI) insult significantly increased microRNA 210 (miR210) in the brain. Of particular importance, we found that inhibition of miR210 significantly reduced HI-induced brain injury and improved long-term neurobehavioral function recovery. MiR210 is The Master Hypoxamir of a specific group of miRs termed ?Hypoxamirs? that are regulated by hypoxia. MiRs are important players in the epigenetic control of gene expression, and silence gene expression by binding to 3?-untranslated region (3?UTR) of transcripts, resulting in transcript degradation or translational inhibition of the target genes. Recent studies have revealed an important role of miRs in the regulation of both innate and adaptive immune cell function. Neuroinflammation is a critical contributor to perinatal hypoxic- ischemic brain injury. Yet, the mechanisms of miRs in the regulation of neuroinflammation in neonatal hypoxic-ischemic brain injury remain unknown. Our preliminary studies demonstrated that hypoxic-ischemic insult activated microglia and increased pro-inflammatory cytokines and lymphocyte infiltration in the neonatal brain. Of importance, the preliminary data showed a potential role of miR210 in the regulation of inflammatory response in the brain, suggesting a highly novel mechanism of miR210-mediated neuroinflammation in perinatal hypoxic-ischemic brain injury. These exciting findings provide a strong scientific premise for us to move forward to explore mechanisms of miR210 in the understanding of perinatal hypoxic-ischemic brain injury. Thus, the proposed study will test the hypothesis that miR210 plays a key role in regulating neuroinflammation that contributes to perinatal hypoxic-ischemic brain injury. The outcome of the proposed study will have major impact in advancing our knowledge in the molecular mechanisms underlying perinatal hypoxic-ischemic brain injury, and provide new insights and a proof of concept in a novel target of epigenetic regulation in potential therapeutic strategies that may be beneficial for the treatment of infants with hypoxic-ischemic brain damage. This is of critical importance given the extreme limit of effective therapeutic intervention currently available other than hypothermia for this important clinical problem in newborns.

Public Health Relevance

Perinatal hypoxic-ischemic encephalopathy (HIE) is associated with high neonatal mortality and severe long-term neurologic morbidity. The molecular mechanisms and the pathway of brain injury in infants with HIE remain largely elusive. Although therapeutic hypothermia is the current standard of care for newborns with moderate to severe HIE, nearly half of affected infants treated with hypothermia still die or suffer significant neurologic disability. Thus, there is an urgent need to further investigate the underlying mechanisms and to develop additional treatment strategies. The proposed study will provide new insights into the molecular mechanisms and a novel target of potential therapeutic strategies that may be beneficial for the treatment of infants with hypoxic-ischemic brain damage, of which the effective therapeutic intervention currently available is limited.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS103017-02
Application #
9503813
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Koenig, James I
Project Start
2017-07-01
Project End
2019-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Loma Linda University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009656273
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Concepcion, Katherine R; Zhang, Lubo (2018) Corticosteroids and perinatal hypoxic-ischemic brain injury. Drug Discov Today 23:1718-1732
Huang, Lei; Ma, Qingyi; Li, Yong et al. (2018) Inhibition of microRNA-210 suppresses pro-inflammatory response and reduces acute brain injury of ischemic stroke in mice. Exp Neurol 300:41-50
Li, Yong; Huang, Lei; Ma, Qingyi et al. (2018) Repression of the Glucocorticoid Receptor Aggravates Acute Ischemic Brain Injuries in Adult Mice. Int J Mol Sci 19:
Li, Bo; Meng, Xianmei; Zhang, Lubo (2018) microRNAs and cardiac stem cells in heart development and disease. Drug Discov Today :
Ma, Qingyi; Zhang, Lubo (2018) C-type natriuretic peptide functions as an innate neuroprotectant in neonatal hypoxic-ischemic brain injury in mouse via natriuretic peptide receptor 2. Exp Neurol 304:58-66
Huang, Lei; Zhang, Lubo (2018) Neural stem cell therapies and hypoxic-ischemic brain injury. Prog Neurobiol :
Li, Bo; Concepcion, Katherine; Meng, Xianmei et al. (2017) Brain-immune interactions in perinatal hypoxic-ischemic brain injury. Prog Neurobiol 159:50-68
Ma, Qingyi; Dasgupta, Chiranjib; Li, Yong et al. (2017) MicroRNA-210 Suppresses Junction Proteins and Disrupts Blood-Brain Barrier Integrity in Neonatal Rat Hypoxic-Ischemic Brain Injury. Int J Mol Sci 18:
Wang, Lei; Ke, Jun; Li, Yong et al. (2017) Inhibition of miRNA-210 reverses nicotine-induced brain hypoxic-ischemic injury in neonatal rats. Int J Biol Sci 13:76-84